APG Asset Management N.V. acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 28,102 shares of the medical technology company's stock, valued at approximately $4,830,000. APG Asset Management N.V. owned approximately 0.06% of Teleflex at the end of the most recent quarter.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Headlands Technologies LLC purchased a new position in Teleflex during the 4th quarter worth approximately $29,000. Avior Wealth Management LLC boosted its position in shares of Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock worth $50,000 after buying an additional 125 shares during the period. IFP Advisors Inc grew its holdings in shares of Teleflex by 238.5% during the fourth quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after buying an additional 217 shares in the last quarter. Exchange Traded Concepts LLC raised its position in Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after buying an additional 94 shares during the period. Finally, R Squared Ltd purchased a new stake in Teleflex in the 4th quarter worth about $64,000. 95.62% of the stock is currently owned by institutional investors and hedge funds.
Teleflex Price Performance
Shares of TFX stock traded up $1.41 during mid-day trading on Thursday, reaching $129.62. The company's stock had a trading volume of 100,567 shares, compared to its average volume of 617,388. The firm's 50-day moving average is $145.36 and its two-hundred day moving average is $179.57. The company has a market cap of $6.01 billion, a P/E ratio of 25.75, a PEG ratio of 1.73 and a beta of 1.19. Teleflex Incorporated has a 1-year low of $124.66 and a 1-year high of $249.91. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42.
Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.86 by $0.03. The firm had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. On average, research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.05%. Teleflex's dividend payout ratio is currently 95.77%.
Analysts Set New Price Targets
A number of brokerages have recently weighed in on TFX. Citizens Jmp downgraded Teleflex from an "outperform" rating to a "market perform" rating in a report on Thursday, February 27th. Wells Fargo & Company cut their target price on shares of Teleflex from $214.00 to $146.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Royal Bank of Canada cut shares of Teleflex from an "outperform" rating to a "sector perform" rating and lowered their price target for the company from $220.00 to $155.00 in a report on Friday, February 28th. Bank of America lowered Teleflex from a "neutral" rating to an "underperform" rating and cut their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Finally, Truist Financial lowered their target price on Teleflex from $149.00 to $140.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $169.63.
Check Out Our Latest Stock Analysis on TFX
Teleflex Company Profile
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Recommended Stories

Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.